Inotek Pharmaceuticals is a clinical-stage drug development company developing therapies with novel mechanisms to address significant diseases of the eye. The Company's lead program, INO-8875, is being evaluated for the treatment of elevated intraocular pressure associated with open-angle glaucoma and ocular hypertension. INO-8875 has completed a Phase 1/2 clinical trial in glaucoma subjects. Treatment with INO-8875 was well tolerated and resulted in a statistically significant reduction in intraocular pressure. It is based in Lexington, Massachusetts.

Property Value
dbo:abstract
  • Inotek Pharmaceuticals is a clinical-stage drug development company developing therapies with novel mechanisms to address significant diseases of the eye. The Company's lead program, INO-8875, is being evaluated for the treatment of elevated intraocular pressure associated with open-angle glaucoma and ocular hypertension. INO-8875 has completed a Phase 1/2 clinical trial in glaucoma subjects. Treatment with INO-8875 was well tolerated and resulted in a statistically significant reduction in intraocular pressure. Additionally, Inotek has a portfolio of emerging programs targeting a broad range of retinal diseases, including age-related macular degeneration and macular edema. It is based in Lexington, Massachusetts. (en)
dbo:wikiPageID
  • 1303484 (xsd:integer)
dbo:wikiPageRevisionID
  • 684627757 (xsd:integer)
dct:subject
http://purl.org/linguistics/gold/hypernym
rdf:type
rdfs:comment
  • Inotek Pharmaceuticals is a clinical-stage drug development company developing therapies with novel mechanisms to address significant diseases of the eye. The Company's lead program, INO-8875, is being evaluated for the treatment of elevated intraocular pressure associated with open-angle glaucoma and ocular hypertension. INO-8875 has completed a Phase 1/2 clinical trial in glaucoma subjects. Treatment with INO-8875 was well tolerated and resulted in a statistically significant reduction in intraocular pressure. It is based in Lexington, Massachusetts. (en)
rdfs:label
  • Inotek (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is foaf:primaryTopic of